Cytodyn Inc (CYDY)

[BlackDoggie]

I agree completely.

Also, I chased down a comment that Pourhassan made right at the end of his piece that caught my ear. If anyone had lingering doubts about whether BP even knows about CYDY... you can probably put that to rest.

https://www.fiercebiotech.com/r-d/2-hiv-drugs-prevent-breast-cancer-metastasis-preclinical-trials

Yes, it's old, but I guarantee it's not forgotten. I bet they all thought Pro 140 would fail as an HIV treatment (see: vicriviroc), and they didn't have the IP for cancer. So why bother? Problem is... it worked for HIV so the company didn't die. Now, their old friend from extremely promising cancer pre-clinical trials went and took his cancer IP to this company they all thought would die. Now the company is worth more than they can pay, but the capital structure and OTC status keeps it at $0.58/share.

This company existing in its current state is an unicorn. I don't think that adequate comps for this situation exist.